| Saunja Carlson, MS SLP-CF | |
|
1957 Alvin Ricken Dr, Pocatello, ID 83201-2727 | |
| (208) 235-7800 | |
| Not Available |
| Full Name | Saunja Carlson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1957 Alvin Ricken Dr, Pocatello, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235584582 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | TSLP-2904 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Saunja Carlson, MS SLP-CF 25117 Sw Parkway Ave Ste D, Wilsonville, OR 97070-9697 Ph: () - | Saunja Carlson, MS SLP-CF 1957 Alvin Ricken Dr, Pocatello, ID 83201-2727 Ph: (208) 235-7800 |
News Archive
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
Hepatic alanine aminotransferase flares are associated with rapid decline and greater annual reductions of hepatitis B surface antigen in patients with chronic hepatitis B virus infection who achieve HBsAg seroclearance, say Japanese researchers.
With a 21 percent Medicare reimbursement rate cut set for Monday, unless Congress acts to block it, some doctors are threatening to refuse new Medicare patients in their practices.
Emerging Healthcare Solutions, Inc. announced today that the Company has signed an option with Regenevita, owner of the right to license Neo Natal Progenitor Cell Expansion Technology in Latin America. The core technology on which the Regenevita technology is based was originally developed by NASA, the National Aeronautics and Space Administration, and was sub-licensed to Regenevita for use with Neo Natal Progenitor Cell Expansion.
Pulmonary embolism (PE), a blood clot in the lungs which causes shortness of breath and chest pain, is the third leading cardiovascular cause of death in the United States with more than 100, 000 lives taken each year.
› Verified 5 days ago
Mrs. Molly Lee Hill, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 611 Wilson Ave Ste 6c, Pocatello, ID 83201 Phone: 208-530-0872 | |
Beth Agres, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1001 N 7th Ave, Pocatello, ID 83201 Phone: 208-239-1490 | |
Kami Anne Westover, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1110 Call Creek Dr Ste 4b, Pocatello, ID 83201 Phone: 208-233-4660 Fax: 208-233-4262 | |
Cheryl Zaremba, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 896 Lucille Ave, Pocatello, ID 83201 Phone: 208-234-7302 | |
Mr. James Ellis Williams Ii, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 527 Memorial Dr, Pocatello, ID 83201 Phone: 801-419-8096 | |
Mrs. Heather L. Rogers, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1110 Call Creek Dr Ste 7, Pocatello, ID 83201 Phone: 208-233-4660 Fax: 208-233-4262 | |
Amanda Taylor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1071 Renee Ave, Pocatello, ID 83201 Phone: 208-233-1411 |